On July 21 a Shanghai Sci‑Tech Innovation Fund portfolio company, Zhuhai Tainuo
Maibo Pharmaceutical, listed on the STAR Market, raising the fund's portfolio
IPO count to 228. The fund targets 30 bln yuan and currently manages more than
20 bln yuan. It has invested in over 100 sub‑funds and has signed sub‑fund
commitments of roughly 300 bln yuan. The portfolio includes over 3,000
companies, 228 listed firms (95 on the STAR Market) and more than 780
national-level specialized and innovative "little giant" enterprises.